Event Abstract

Determination of anti-Mycobacterium tuberculosis IgM and IgG antibodies in individuals in contact with patients with active tuberculosis.

  • 1 Facultad de Medicina U.A.N.L., Inmunologia, Mexico
  • 2 Facultad de Medicina, U.A.N.L., Inmunología, Mexico

INTRODUCTION: Tuberculosis is a global health issue, and a third of the entire population is infected with the bacilli. In 2013, 8.9 millions of infected patients were reported and 1.5 million of these died. The cellular immune response by Th1 cells appears to be responsible for the resolution and protection against the disease, and the humoral immune response, although not much involved in this protection, is useful as a diagnostic tool. In general, the production of IgM antibodies takes place during the acute or latent phase of most infectious diseases and their serum levels decrease during the chronic phase. On the other hand, IgG antibodies increase during the active infection and their levels remain high even after the infection is resolved, becoming the immunological memory. The OBJECTIVE of this work was to determine the presence of anti-M. tuberculosis IgM and IgG in serum of individuals in contact with patients with pulmonary tuberculosis. METHODOLOGY: We obtained sera from 46 clinically healthy individuals, from 77 persons that were in contact with patients with tuberculosis for at least 6 hours a day, and from 28 patients with pulmonary tuberculosis diagnosed clinically, radiologically and with a positive culture. We used ELISA plates covered with antigens obtained from a purified extract of extracellular proteins of the H37 Rv strain, including ESAT6 and CFP10 (Patent Nº 285260 “Process for the detection of tuberculosis”). The antibodies present in the sera of healthy subjects, contacts, and patients were developed with anti-IgM and anti-IgG antibodies conjugated with peroxidase. All subjects were tested with the PPD cutaneous reaction to evaluate the efficacy of our ELISA method. RESULTS: IgM+/IgG- or IgM+/IgG+ indicates a tuberculosis infection; IgM-/IgG+ indicates immunological memory or that the TB infection was in the process of resolving; and IgM-/IgG- indicates no infection with Mycobacterium tuberculosis. We found that IgM was positive (+) in 2/46 (4.3%) of healthy patients, in 72/77 (93.5%) of contacts, and in 27/28 (96.4 %) of patients with TB. IgG was positive (+) in 26/46 (56.5%) of healthy patients, 31/77 (40.22%) of contacts, and 13/28 (46.4%) of patients with TB. The reaction to the PPD (48-72 hours) was positive (> 5mm) in 20/46 (43%) of healthy patients, 55/77 (71.4%) of contacts, and 28/28 (100%) of patients with TB. CONCLUSION: IgM and IgG positive sera from contacts of infected patients suggest they could be infected with M. tuberculosis. The presence of IgG but not IgM in a 56.5% of healthy individuals could be interpreted as immunological memory. The fact that 96.4% of sera from sick patients was positive for IgM indicates that the ELISA method that we used is useful for the diagnosis of latent and active tuberculosis. The PPD cutaneous reaction was less efficient in diagnosing a latent infection in contacts of sick patients compared to our ELISA method. This proofs that the ELISA method we use could be useful for the prompt detection of the M. tuberculosis infection, allowing for the control of the disease.

Keywords: Tuberculosis, Pulmonary, ELISA, IgM, Mycobacterium tuberculosis, Individuals contacts

Conference: IMMUNOCOLOMBIA2015 - 11th Congress of the Latin American Association of Immunology - 10o. Congreso de la Asociación Colombiana de Alergia, Asma e Inmunología, Medellin, Colombia, 13 Oct - 16 Oct, 2015.

Presentation Type: Poster Presentation

Topic: Infectious and parasitic diseases

Citation: Arce Mendoza AY, Cantú Rodríguez MP, Ramírez Vega JA, Rosas Taraco AG and Limón Flores AY (2015). Determination of anti-Mycobacterium tuberculosis IgM and IgG antibodies in individuals in contact with patients with active tuberculosis.. Front. Immunol. Conference Abstract: IMMUNOCOLOMBIA2015 - 11th Congress of the Latin American Association of Immunology - 10o. Congreso de la Asociación Colombiana de Alergia, Asma e Inmunología. doi: 10.3389/conf.fimmu.2015.05.00157

Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.

The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.

Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.

For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.

Received: 30 May 2015; Published Online: 14 Sep 2015.

* Correspondence: PhD. Alma Y Arce Mendoza, Facultad de Medicina U.A.N.L., Inmunologia, Monterrey, Nuevo León, 64460, Mexico, aya.mayola@yahoo.com